Proceedings for Annual Meeting of The Japanese Pharmacological Society
Online ISSN : 2435-4953
The 97th Annual Meeting of the Japanese Pharmacological Society
Session ID : 97_1-B-SL05
Conference information

Special Lectures
New technology and Information Science for Next Generation Drug Modalities
*Kouhei Tsumoto
Author information
CONFERENCE PROCEEDINGS OPEN ACCESS

Details
Abstract

Antibody as a drug modality contributes to the first runner of biomedicine. Recently, research and development of next generation antibody drugs has remarkable progresses on therapy, e.g. antibody drug conjugate (ADC), bispecific antibody (bsAb), and single domain antibody (VHH, also called nanobody), which has widen the application areas of antibody drugs. These include combination of elemental technologies, and incorporation of information sciences into the drug development. Here I would discuss next generation drug modality, especially focusing on innovation-driven antibody engineering.

Content from these authors
© 2023 The Authors(s)
Previous article Next article
feedback
Top